A reformulated COVID-19 vaccine booster that targets the original Alpha coronavirus as well as the circulating Omicron variant, recently met with conditional approval by the U.S. Food and Drug Administration and a recommendation from the U.S. Centers for Disease Control and Prevention. Dr. Joe Thompson, President and CEO of the Arkansas Center for Health Improvement headquartered in Little Rock, provides guidance.